← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 5,365

Funds Holding Change +8

Funds Holding Growth +0.1%

Value $1.31T

Holding in Top 10 768

Top 10 Change +100

Top 10 Growth +15%

Value Growth +7%

New 235

Increased 2,555

Reduced 2,219

Closed 146

Capital Inflow $92.4B

Capital Outflow $40.4B

Net Capital Flow +$52B

Capital Flow Change +$44.9B

Calls $21.9B

Puts $22.3B

Net Calls -$443M

Put/Call Ratio 1.02